Education
About Us
Working with TipRanks
Follow Us
Tivic Health Systems (TIVC)
NASDAQ:TIVC
TIVC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.43 - $16.07
Previous CloseN/A
Volume226.20K
Average Volume (3M)48.77K
Market Cap
$3.68M
Enterprise Value$3.20M
Total Cash (Recent Filing)$669.00K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.37
Next Earnings
Aug 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.52
Shares Outstanding965,899
10 Day Avg. Volume25,876
30 Day Avg. Volume48,772
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)1.71
Price to Sales (P/S)0.00
P/FCF Ratio-0.69
Enterprise Value/Market Cap0.87
Enterprise Value/Revenue0.95
Enterprise Value/Gross Profit-27.86
Enterprise Value/Ebitda-0.13
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Tivic Health Systems News
PremiumCompany Announcements
Tivic Health Advances TLR5 Immunotherapy Program
PremiumCompany Announcements
Tivic Health Systems Announces Virtual Annual Meeting
PremiumCompany Announcements
Tivic Health’s Strategic Shift: Earnings Call Insights
PremiumCompany Announcements
Tivic Health Expands Clinical Pipeline Amid Financial Challenges
PremiumCompany Announcements
Tivic Health Systems Announces Q1 2025 Financial Results
PremiumCompany Announcements
Tivic Health Systems Partners with Scorpius BioManufacturing
Options Prices
Currently, No data available
---
Ownership Overview
12.75% Insiders
0.85% Mutual Funds
0.41% Other Institutional Investors
85.48% Public Companies and Individual Investors
TIVC FAQ
What was Tivic Health Systems’s price range in the past 12 months?
Tivic Health Systems lowest stock price was $2.43 and its highest was $16.07 in the past 12 months.
What is Tivic Health Systems’s market cap?
Tivic Health Systems’s market cap is $3.68M.
When is Tivic Health Systems’s upcoming earnings report date?
Tivic Health Systems’s upcoming earnings report date is Aug 18, 2025 which is in 64 days.
How were Tivic Health Systems’s earnings last quarter?
Tivic Health Systems released its earnings results on May 15, 2025. The company reported -$2.519 earnings per share for the quarter, missing the consensus estimate of N/A by -$2.519.
Is Tivic Health Systems overvalued?
According to Wall Street analysts Tivic Health Systems’s price is currently Overvalued.
Does Tivic Health Systems pay dividends?
Tivic Health Systems does not currently pay dividends.
What is Tivic Health Systems’s EPS estimate?
Tivic Health Systems’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tivic Health Systems have?
Tivic Health Systems has 965,899 shares outstanding.
What happened to Tivic Health Systems’s price movement after its last earnings report?
Tivic Health Systems reported an EPS of -$2.519 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.157%.
Which hedge fund is a major shareholder of Tivic Health Systems?
Currently, no hedge funds are holding shares in TIVC
Tivic Health Systems Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 7.1%
Last 30 Days ▼ 7.1%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-42.21%
12-Months-Change
Fundamentals
Return on Equity
-218.77%
Trailing 12-Months
Asset Growth
14.94%
Trailing 12-Months
Company Description
Tivic Health Systems
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
TIVC Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a period of significant strategic transformation for Tivic Health, with promising developments in their transition to a diversified immunotherapeutics company. The acquisition of Entolimod and advancements toward commercialization present considerable growth opportunities. However, the company faces financial challenges with declining revenue and cash reserves, balancing the positive strategic shifts.Read More>Technical Analysis
Helius Medical Technologies
―
Catheter Precision
―
Bone Biologics
―
INVO Fertility
―
Bluejay Diagnostics
―